Results 41 to 50 of about 6,287 (219)

Photoactivatable senolysis with single-cell resolution delays aging [PDF]

open access: yes, 2023
Strategies that can selectively eliminate senescent cells (SnCs), namely senolytics, have been shown to promote healthy lifespan. However, it is challenging to achieve precise, broad-spectrum and tractable senolysis.
Gao, Ying   +8 more
core   +3 more sources

Senolytic drugs: from discovery to translation [PDF]

open access: yesJournal of Internal Medicine, 2020
AbstractSenolytics are a class of drugs that selectively clear senescent cells (SC). The first senolytic drugs Dasatinib, Quercetin, Fisetin and Navitoclax were discovered using a hypothesis‐driven approach. SC accumulate with ageing and at causal sites of multiple chronic disorders, including diseases accounting for the bulk of morbidity, mortality ...
J. L. Kirkland, T. Tchkonia
openaire   +2 more sources

Endothelial Senescence and the Chronic Vascular Diseases: Challenges and Therapeutic Opportunities in Atherosclerosis [PDF]

open access: yes, 2022
Atherosclerosis is probably one of the paradigms of disease linked to aging. Underlying the physiopathology of atherosclerosis are cellular senescence, oxidative stress, and inflammation.
Alique Aguilar, Matilde   +5 more
core   +1 more source

DNA damage: A main determinant of vascular aging [PDF]

open access: yes, 2016
Vascular aging plays a central role in health problems and mortality in older people. Apart from the impact of several classical cardiovascular risk factors on the vasculature, chronological aging remains the single most important determinant of ...
Bautista-Niño, P.K. (Paula)   +4 more
core   +2 more sources

From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs

open access: yesOpen Biology, 2022
Senescence is a cellular stress response that involves prolonged cell survival, a quasi-irreversible proliferative arrest and a modification of the transcriptome that sometimes includes inflammatory gene expression.
Valentin L'Hôte   +2 more
doaj   +1 more source

The Evolving Role of CD8+CD28- Immunosenescent T Cells in Cancer Immunology [PDF]

open access: yes, 2019
Functional, tumor-specific CD8+ cytotoxic T lymphocytes drive the adaptive immune response to cancer. Thus, induction of their activity is the ultimate aim of all immunotherapies.
Dey, Mahua   +4 more
core   +1 more source

From genoprotection to rejuvenation

open access: yesFrontiers in Bioscience-Landmark, 2020
Aging results from aberrations in signaling mechanisms and decline in biologic activities and cellular functions. Anti-aging strategies include a number of dietary, genetic, and pharmacological interventions that converge on a core network of nutrient ...
Siamak Tabibzadeh
doaj   +1 more source

New Trends in Aging Drug Discovery [PDF]

open access: yes, 2022
Aging is considered the main risk factor for many chronic diseases that frequently appear at advanced ages. However, the inevitability of this process is being questioned by recent research that suggests that senescent cells have specific features that ...
Benhamú Salama, Bellinda   +4 more
core   +2 more sources

Rapamycin treatment increases survival, autophagy biomarkers and expression of the anti‐aging klotho protein in elderly mice

open access: yesPharmacology Research & Perspectives, 2023
Previous investigations have demonstrated that treatment of animals with rapamycin increases levels of autophagy, which is a process by which cells degrade intracellular detritus, thus suppressing the emergence of senescent cells, whose pro‐inflammatory ...
Kitti Szőke   +8 more
doaj   +1 more source

Send in the senolytics [PDF]

open access: yesNature Biotechnology, 2020
Despite early failures in the clinic, the idea of anti-aging therapies that purge the body of dying cells is gaining traction with a raft of startups now focused on senescence.
openaire   +1 more source

Home - About - Disclaimer - Privacy